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Abstract Regulated exocytosis establishes a narrow fusion pore as initial aqueous connection to
the extracellular space, through which small transmitter molecules such as ATP can exit. Co-release
of polypeptides and hormones like insulin requires further expansion of the pore. There is evidence
that pore expansion is regulated and can fail in diabetes and neurodegenerative disease. Here, we
report that the cAMP-sensor Epac2 (Rap-GEF4) controls fusion pore behavior by acutely recruiting
two pore-restricting proteins, amisyn and dynamin-1, to the exocytosis site in insulin-secreting
beta-cells. cAMP elevation restricts and slows fusion pore expansion and peptide release, but not
when Epac2 is inactivated pharmacologically or in Epac2-/- (Rapgef4-/-) mice. Consistently,
overexpression of Epac2 impedes pore expansion. Widely used antidiabetic drugs (GLP-1 receptor
agonists and sulfonylureas) activate this pathway and thereby paradoxically restrict hormone
release. We conclude that Epac2/cAMP controls fusion pore expansion and thus the balance of
hormone and transmitter release during insulin granule exocytosis.
DOI: https://doi.org/10.7554/eLife.41711.001
Introduction
Insulin is secreted from pancreatic b-cells and acts on target tissues such as muscle and liver to regu-
late blood glucose. Secretion of insulin occurs by regulated exocytosis, whereby secretory granules
containing the hormone and other bioactive peptides and small molecules fuse with the plasma
membrane. The first aqueous contact between granule lumen and the extracellular space is a narrow
fusion pore (upper limit 3 nm; Albillos et al., 1997) that is thought to consist of both lipids and pro-
teins (Bao et al., 2016; Sharma and Lindau, 2018). At this stage, the pore acts as a molecular sieve
that allows release of small transmitter molecules such as nucleotides and catecholamines, but traps
larger cargo (Obermüller et al., 2005; Barg et al., 2002; MacDonald et al., 2006; Alvarez de
Toledo et al., 1993). Electrophysiological experiments have shown that the fusion pore is short-lived
and flickers between closed and open states, suggesting that mechanisms exist that stabilize this
channel-like structure and restrict pore expansion (MacDonald et al., 2006; Hanna et al., 2009;
Breckenridge and Almers, 1987; Lollike et al., 1995). The pore can then expand irreversibly
(termed full fusion), which leads to mixing of granule and plasma membrane and release of the bulk-
ier hormone content (Obermüller et al., 2005; Barg et al., 2002; Anantharam et al., 2010). Alter-
natively, the pore can close indefinitely to allow the granule to be retrieved, apparently intact, into
the cell interior (termed kiss-and-run or cavicapture) (Obermüller et al., 2005; MacDonald et al.,
2006; Taraska et al., 2003; Tsuboi and Rutter, 2003; Shin et al., 2018). Estimates in b-cells sug-
gest that 20–50% of all exocytosis in b-cells are transient kiss-and-run events that do not lead to insu-
lin release (Obermüller et al., 2005; MacDonald et al., 2006). However, kiss-and-run exocytosis
contributes to local signaling within the islet because smaller granule constituents, such as
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nucleotides, glutamate or GABA, are released even when the fusion pore does not expand. Within
the islet, ATP synchronizes b-cells (Hellman et al., 2004), and has both inhibitory (Salehi et al.,
2005; Poulsen et al., 1999) and stimulatory (Richards-Williams et al., 2008) effects on insulin secre-
tion. ATP suppresses glucagon release from a-cells (Tudurı́ et al., 2008), and activates macrophages
(Weitz et al., 2018). Interstitial GABA leads to tonic GABA-A receptor activation and a-cell prolifer-
ation (Jin et al., 2013; Ben-Othman et al., 2017), and glutamate stimulates glucagon secretion
(Cabrera et al., 2008).
Regulation of fusion pore behavior is not understood mechanistically, but several cellular signal-
ing events affect both lifetime and flicker behavior. Pore behavior has been shown to be regulated
by cytosolic Ca2+, cAMP, PI(4,5)P2, and activation of protein kinase C (PKC) (MacDonald et al.,
2006; Hanna et al., 2009; Alés et al., 1999; Calejo et al., 2013; Scepek et al., 1998) and recent
superresolution imaging indicates that elevated Ca2+ and dynamin promote pore closure
(Shin et al., 2018; Chiang et al., 2014). Both myosin and the small GTPase dynamin are involved in
fusion pore restriction (Jackson et al., 2015; Tsuboi et al., 2004; Graham et al., 2002;
Artalejo et al., 1995; Aoki et al., 2010), and assembly of filamentous actin promotes fusion pore
expansion (Wen et al., 2016), suggesting a link to endocytosis and the cytoskeleton. In b-cells of
type-2 diabetics, upregulation of amysin leads to decreased insulin secretion because fusion pore
expansion is impaired (Collins et al., 2016), and the Parkinson’s related protein a-synuclein pro-
motes fusion pore dilation in chromaffin cells and neurons (Logan et al., 2017), thus providing evi-
dence for altered fusion pore behavior in human disease.
Inadequate insulin secretion in type-2 diabetes (T2D) is treated clinically by two main strategies.
First, sulfonylureas (e.g. tolbutamide and glibenclamide) close the KATP channel by binding to its reg-
ulatory subunit SUR1, which leads to increased electrical activity and Ca2+-influx that triggers insulin
secretion (Henquin, 2000). Sulfonylureas are given orally and are first-line treatment for type-2 dia-
betes in many countries. Second, activation of the receptor for the incretin hormone glucagon-like
eLife digest Insulin is the hormone that signals to the body to take up sugar from the blood.
Specialized cells in the pancreas – known as b-cells – release insulin after a meal. Before that, insulin
molecules are stored in tiny granules inside the b-cells; these granules must fuse with the cells’
surface membranes to release their contents. The first step in this process creates a narrow pore
that allows small molecules, but not the larger insulin molecules, to seep out. The pore then widens
to release the insulin. Since the small molecules are known to act locally in the pancreas, it is
possible that this “molecular sieve” is biologically important. Yet it is not clear how the pore widens.
One of the problems for people with type 2 diabetes is that they release less insulin into the
bloodstream. Two kinds of drugs used to treat these patients work by stimulating b-cells to release
their insulin. One way to achieve this is by raising the levels of a small molecule called cAMP, which
is well known to help prepare insulin granules for release. The cAMP molecule also seems to slow
the widening of the pore, and Gucek et al. have now investigated how this happens at a molecular
level.
By observing individual granules of human b-cells using a special microscope, Gucek et al. could
watch how different drugs affect pore widening and content release. They also saw that cAMP
activated a protein called Epac2, which then recruited two other proteins – amisyn and dynamin – to
the small pores. These two proteins together then closed the pore, rather than expanding it to let
insulin out. Type 2 diabetes patients sometimes have high levels of amisyn in their b-cells, which
could explain why they do not release enough insulin. The microscopy experiments also revealed
that two common anti-diabetic drugs activate Epac2 and prevent the pores from widening, thereby
counteracting their positive effect on insulin release. The combined effect is likely a shift in the
balance between insulin and the locally acting small molecules.
These findings suggest that two common anti-diabetic drugs activate a common mechanism that
may lead to unexpected outcomes, possibly even reducing how much insulin the b-cells can release.
Future studies in mice and humans will have to investigate these effects in whole organisms.
DOI: https://doi.org/10.7554/eLife.41711.002
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peptide 1 (GLP-1) raises cytosolic [cAMP] and thereby increases the propensity of insulin granules to
undergo exocytosis. Both peptide agonists of the GLP-1 receptor (e.g. exendin-4) and inhibitors of
DPP-4 are used clinically for this purpose. The effect of cAMP on exocytosis is mediated by a pro-
tein-kinase A (PKA)-dependent pathway, and by Epac2, a guanine nucleotide exchange factor for
the Ras-like small GTPase Rap (Kawasaki et al., 1998) that is a direct target for cAMP (Ozaki et al.,
2000) and is recruited to insulin granule docking sites (Alenkvist et al., 2017). Epac2 has also been
suggested to be activated by sulfonylureas (Zhang et al., 2009), which may underlie some of their
effects on insulin secretion.
Here, we have studied fusion pore regulation in pancreatic b-cells, using high-resolution live-cell
imaging. We report that activation of Epac2, either through GLP1-R/cAMP signaling or via sulfonyl-
urea, restricts expansion of the insulin granule fusion pore by recruiting dynamin and amisyn to the
exocytosis site. Activation of this pathway by two classes of antidiabetic drugs therefore hinders full
fusion and insulin release, which is expected to reduce their effectiveness as insulin secretagogues.
Results
cAMP-dependent fusion pore restriction is regulated by Epac but not
PKA
To monitor single granule exocytosis, human pancreatic b-cells were infected with adenovirus encod-
ing the granule marker NPY-Venus and imaged by TIRF microscopy. Exocytosis was evoked by local
application of a solution containing 75 mM K+, which leads to rapid depolarization and Ca2+ influx.
Visually, two phenotypes of granule exocytosis were observed. In the first, termed full fusion, fluores-
cence of a granule that was stably situated at the plasma membrane suddenly vanished during the
stimulation (in most cases within <100 ms; Figure 1a–c, left panels). Since the EGFP label is relatively
large (3.7 nm vs 3 nm for insulin monomers), this is interpreted as rapid pore widening that allowed
general release of granule cargo. The sudden release of material may suggest that this release coin-
cided with the collapse of the granule into the plasma membrane, but we cannot exclude that at
least some granules remained intact (Taraska et al., 2003; Shin et al., 2018; Tsuboi et al., 2004;
Huang et al., 2018). In the second type, the rapid loss of the granule marker was preceded by an
increase in its fluorescence that could last for several seconds (flash events, Figure 1a–c, right pan-
els). We and others have previously shown (Taraska et al., 2003; Ferraro et al., 2005; Gandasi and
Barg, 2014) that this reflects neutralization of the acidic granule lumen and dequenching of the
EGFP-label, before the labeled cargo is released. Since this neutralization occurs as the result of pro-
ton flux through the fusion pore, the fluorescence timecourse of these events can be used to quanti-
tatively study fusion pore behavior.
In the following, we will report two parameters that reflect fusion pore behavior, the fraction of
exocytosis events with flash phenotype (indicating restricted pores, about 40% in control conditions;
Figure 1d), and the duration of the flash, referred to as ‘NPY release times’. The latter was esti-
mated by fitting a discontinuous function to the fluorescence timecourse (see Figure 1c, green lines
and Figure 1e), which limits the analysis to granules that eventually released their peptide content.
The distribution of the NPY release times followed a mono-exponential function and was on average
0.87 ± 0.12 s (186 granules in 26 cells) in control conditions (Figure 1e). Such events are increased
by elevated cAMP (MacDonald et al., 2006; Hanna et al., 2009) and likely other conditions that sta-
bilize the fusion pore. Indeed, when forskolin (2 mM; fsk) was added to the bath solution we
observed a twofold increase of exocytosis rate (Figure 1f), a threefold increase of NPY release times
(Figure 1e), and a nearly doubled fraction of events with restricted fusion pores (Figure 1d,f). The
GLP-1 agonist exendin-4 (10 nM; Ex4) had comparable effects (Figure 1d–f). Effects similar to those
observed for human b-cells (Figure 1) were observed in the insulin secreting cell line INS-1 (Fig-
ure 1—figure supplement 1).
The effect of fsk on fusion pore behavior was mimicked by the specific Epac2 agonist S223
(Schwede et al., 2015). Incubation with S223-acetomethoxyester (5 mM) increased the fraction of
flash events by 60% (Figure 1d), doubled average NPY release times (Figure 1e) and doubled the
event frequency (Figure 1f); the effects of fsk and S223 were not additive. In contrast, the Epac-
inhibitor ESI-09 decreased the exocytosis rate in the presence of fsk by 80% (Figure 1f), and the
average NPY release time and the fraction of flash events were both reduced by 60% (Figure 1d–e).
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PKA inhibition with Rp8-Br-cAMPS (Gjertsen et al., 1995) decreased neither the fraction of flash
events, nor average NPY release times (Figure 1e). The results indicate that Epac rather than PKA is
responsible for cAMP-dependent fusion pore regulation. Paradoxically, Epac activation increases the
rate of exocytosis but slows the rate of peptide release from individual granules.
Figure 1. cAMP-dependent fusion pore restriction depends on Epac (but not PKA). (a) Examples of single granule
exocytosis in human b-cells expressing NPY-Venus and challenged with 75 mM K+. Full fusion (left) and flash event
(right), where sudden loss of the granule label was preceded by a transient fluorescence increase. Arrows indicate
moment of fusion pore opening (orange) and content release (blue). (b) Cartoons illustrating the interpretation of
events in a. (c) Fluorescence time courses for the events in b. Overlaid (green) are fitted functions used to estimate
NPY release time. (d) Fraction of flash events in experiments as in a-c, in cells exposed to the indicated agents;
forskolin (fsk, p=0.01 vs ctrl), exendin-4 (Ex4, p=0.02 vs ctrl), ESI-09 (p=3*10 4 vs fsk), S223 (p=0.04 vs ctrl),
fsk +S223 (p=0.99 vs fsk), RP-8 (p=0.91 vs fsk) and Rp-8 +S223 (p=0.19 vs ctrl; Kruskal Wallis/Dunn). Number of
donors analyzed: 7 (CTR); 5 (fsk); 4 (Ex4); 7 (fsk +ESI09); 6 (S223); 6 (fsk +S223); 7 (RP-8); 4 (Rp-8 +S223). n, number
of cells. (e) Cumulative frequency histograms of NPY release times; fsk (p=9*10 7 vs ctrl), Ex4 (p=1*10 6 vs ctrl),
ESI-09 (p=2*10 4 vs fsk), S223 (p=4*10 6 vs ctrl),Fsk +S223 (n.s. vs fsk), RP-8 (n.s. vs fsk) and RP-8 +S223 (p=0.016
vs ctrl); Kolmogorov-Smirnov test). Inset shows median NPY release times for 170 (CTR), 197 (fsk), 155 (Ex4), 81
(ESI-09), 240 (S223), 328 (fsk +S223), 277 (RP-8) and 227 (Rp-8 +S223) events. (f) Exocytosis during 40 s of K+-
stimulation for control (CTR) and with forskolin (fsk, 2 mM, p=0.002 vs ctrl; Kruskal Wallis/Dunn) or Exendin-4 (Ex4,
10 nM, p=0.005 vs ctrl) or S223 (5 mM, p=0.002 vs ctrl) or RP-8 +S223 (p=0.012 vs ctrl and n.s. vs S223) in the bath
solution. Inhibitors of Epac (ESI-09, 10 mM, p=9*10-7 vs fsk) or PKA (RP-8, 100 mM, n.s. vs fsk) or Epac2 activator
S223 (n.s. vs fsk), one-way ANOVA with Games-Howell post hoc test) were supplied in addition to forskolin. Flash
exocytosis (in color) and full fusions (in white) are shown separately. n, number of cells.
DOI: https://doi.org/10.7554/eLife.41711.003
The following figure supplement is available for figure 1:
Figure supplement 1. cAMP increases NPY release times in INS1 cells.
DOI: https://doi.org/10.7554/eLife.41711.004
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Epac2 overexpression restricts fusion pores and prolongs their lifetime
We studied the effect of Epac2 overexpression on fusion pore regulation. INS-1 cells were co-trans-
fected with EGFP-Epac2 and NPY-tdmOrange2 and fluorescence was recorded simultaneously in
both color channels. Epac2 overexpression had no effect on the overall exocytosis rate in either
absence or presence of fsk (Figure 2a), but increased the rate of flash events (Figure 2b–c), support-
ing our finding, based on manipulation of the endogenous Epac2 activity, that Epac2 is involved in
fusion pore regulation (Figure 1d). NPY release times in cells overexpressing Epac2 increased three-
fold in the absence of fsk, and were similar to controls in presence of fsk (Figure 2d). This indicates
that a high Epac concentration can achieve sufficient activity to affect insulin secretion even at basal
cAMP level, likely because cAMP acts in part by increasing the Epac concentration at the plasma
membrane (Alenkvist et al., 2017).
ATP release is accelerated upon Epac inhibition
To test if cAMP-dependent fusion pore restriction affects release of small transmitter molecules, we
quantified nucleotide release kinetics from individual granules using patch clamp electrophysiology.
The purinergic receptor cation channel P2X2, tagged with RFP (P2X2-RFP), was expressed in INS-1
cells as an autaptic nucleotide sensor (Obermüller et al., 2005) (Figure 3a). The cells were voltage-
clamped in whole-cell mode and exocytosis was elicited by including a solution with elevated free
Ca2+ (calculated 600 nM) in the patch electrode. In this configuration, every exocytosis event that
Figure 2. Epac2 overexpression prolongs NPY release times. (a) Cumulative exocytosis in INS-1 cells stimulated
with 75 mM K+; gray for control cells, purple for cells expressing Epac2-EGFP (both also expressed NPY-
tdmOrange2); fsk indicates forskolin in the bath solution. CTR, n = 13 (4 preps); Epac2, n = 11 (2 preps); CTR +fsk,
n = 15 (5 preps); Epac2 +fsk, n = 14 cells (2 preps). (b) Total exocytosis in (a), separated into flash events (color)
and full fusion (white). Epac2 expression reduced full fusion events (no fsk p=0.06; with fsk p=0.01, Kruskal Wallis/
Dunn). n, number of cells. (c) Fraction of flash events in (a–b). (Kruskal Wallis/Dunn). n, number of cells. (d) NPY
release times for conditions in a-c. Epac overexpression increased NPY release times in absence (p=0.014) but not
in presence of fsk (p=0.87, Kolmogorov-Smirnov test). Inset shows the NPY release times for 38 (CTR), 27 (Epac2),
119 (CTR +fsk) and 77 (Epac2 +fsk) events.
DOI: https://doi.org/10.7554/eLife.41711.005
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co-releases nucleotides causes an inward current spike, similar to those observed by carbon fiber
amperometry (Figure 3a–b). Including cAMP in the pipette solution increased the frequency of cur-
rent spikes by 50%, consistent with accelerated exocytosis. This effect of cAMP was blocked if the
Epac inhibitor ESI-09 was present (Figure 3b–c). The current spikes (see Figure 3a, right) reflect
nucleotide release kinetics during individual exocytosis events. In the presence of cAMP, but not
cAMP + ESI-09, they were markedly widened as indicated by on average 20% longer half-widths
(Figure 3d), 30% longer decay constants (t, Figure 3e), and 40% slower rising phases (25–75%
slope, Figure 3f), compared with control. This indicates that nucleotide release is slowed by cAMP,
likely because of changed fusion pore kinetics. Since the effect is blocked by ESI-09, we conclude
that the cAMP effect probably is mediated by Epac.
Figure 3. Cytosolic cAMP slows ATP release by activating Epac. (a) Electrophysiological detection of nucleotide
release events in INS-1 cells expressing P2X2-RFP. Cartoon of the assay (left) and example current spike (black)
with fit and analysis parameters (red; Thalf, tau and slope during 25% to 75% of peak). (b) Representative P2X2
currents for control (black), and with cAMP (green) or with cAMP together with ESI-09 (purple) in the electrode
solution. (c) Spike frequency conditions in (b). n of events (on top) and n of cells (on bars); two preps for each
condition. (d–f) Cumulative frequency histograms of spike half width (d), decay constant tau (e), and slope of the
rising phase (25% and 75% of peak, (f)) for CTR (n = 410 spikes, 14 cells), +cAMP (n = 1240, 14 cells) and +ESI-
09 + cAMP (n = 552, 15 cells) with medians in the insets. cAMP increased half-width (p=4.1*10 31 vs ctrl,
Kolmogorov-Smirnov test), tau (p=2.7*10 32, Kolmogorov-Smirnov test), and rising slope (p=4.7*10 19,
Kolmogorov-Smirnov test); the effects were reversed by ESI-09 (p=3.4*10 21, p=3.6*10 22, and p=1.3*10 9,
Kolmogorov-Smirnov test), respectively.
DOI: https://doi.org/10.7554/eLife.41711.006
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cAMP-dependent fusion pore regulation is absent in Epac2-/-
(Rapgef4-/-) b-cells
Since ESI-09 blocks all Epac isoforms (Zhu et al., 2015), we characterized fusion pore behavior in iso-
lated b-cells from Epac2-/- (Rapgef4-/-) mice that lack all splice variants of Epac2 (Kopperud et al.,
2017). Cells from WT or Epac2-/- mice were infected with adenovirus encoding the granule marker
NPY-tdmOrange2 and challenged with 75 mM K+ (Figure 4a–b). In the absence of forskolin, exocy-
tosis was significantly slower in Epac2-/- cells than WT cells, and the fraction of flash-associated exo-
cytosis events was five-fold lower (Figure 4c–e). This was paralleled by strikingly shorter fusion pore
life-times in Epac2-/- cells compared with WT (Figure 4f). The data suggest that Epac2 is partially
activated in these conditions, consistent with elevated cAMP levels in mouse b-cells in hyperglycemic
conditions (Dyachok et al., 2008). As expected, forskolin increased both exocytosis (Figure 4e) and
the fraction of flash events (Figure 4c) of WT cells. In contrast, forskolin failed to accelerate exocyto-
sis in Epac2-/- cells, and the fraction of flash events was similar with or without forskolin (Figure 4c,f–
g). We conclude therefore that the effects of cAMP on fusion pore behavior are mediated specifi-
cally by Epac2.
Sulfonylureas delay fusion pore expansion through the same pathway
as cAMP
Sulfonylureas have been reported to activate Epac (Zhang et al., 2009), in addition to their classical
role that involves the sulfonylurea receptor (SUR). We therefore tested the effect of sulfonylureas on
fusion pore behavior. INS-1 cells expressing NPY-tdmOrange2 were tested with three types of sulfo-
nylureas, with different relative membrane permeability (tolbutamide < glibenclamide < gliclazide).
In addition, diazoxide (200 mM) was present to prevent electrical activity. Exocytosis was not
observed under these conditions, but could be triggered by local application of elevated K+ (75
mM). In the absence of fsk, the sulfonylureas accelerated K+-stimulated exocytosis about twofold
over that observed in control (Figure 5b, left), which is consistent with earlier findings that sulfony-
lureas augment insulin secretion via intracellular targets (Barg et al., 1999). This effect was entirely
due to an increase in flash-associated exocytosis events (Figure 5b–c) and the average NPY release
time increased accordingly in the presence of sulfonylurea (Figure 5d). Fsk strongly stimulated both
flash-associated and full fusion exocytosis in absence of sulfonylurea (Figure 5b–c, middle); under
these conditions, sulfonylureas tended to decrease full-fusion exocytosis without effect on the fre-
quency of flash-associated events (Figure 5b, middle). Accordingly, NPY release times were elevated
compared with control (no fsk), and only marginally longer than with fsk alone (Figure 5d, right).
Similar results were obtained in human b-cells, where glibenclamide increased exocytosis in the
absence of fsk (p=0.01, n = 13 cells from four donors) but not in its presence (p=0.80, n = 7 cells
from four donors; data not shown). The data indicate that sulfonylureas restrict fusion pore expan-
sion through the same intracellular pathway as cAMP, which may counteract their stimulating effect
on exocytosis by preventing or delaying peptide release.
Sulfonylureas also bind to SUR1 in the plasma membrane, which leads to rapid closure of KATP
channels, depolarization and exocytosis. We tested the involvement of SUR1 by applying sulfonylur-
eas acutely, which is expected to activate SUR1 in the plasma membrane but not Epac the cytosol
(Figure 5e). Reduced diazoxide (50 mM) prevented glucose-dependent exocytosis but still allowed
acute stimulation of exocytosis by sulfonylureas. Under these conditions, the fraction of flash-associ-
ated exocytosis events (Figure 5f–g) and the NPY release times (Figure 5h) were similar to control
(stimulation with elevated K+) for all three sulfonylureas. Taken together, the data suggest that sulfo-
nylureas must enter the cytosol to affect fusion pore behavior, and that this effect is not mediated
by the plasma membrane SUR. We excluded the possibility that sulfonylureas affect the fluorescence
signal indirectly, by altering granule pH (Figure 5—figure supplement 1). Moreover, an EGFP-
tagged SUR1 (EGFP-SUR1) expressed in INS-1 cells did not localize to exocytosis sites or affect
fusion pore behavior (Figure 5—figure supplement 2). We therefore conclude that sulfonylureas
affect fusion pore behavior through Epac2.
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Figure 4. Fusion pores expand rapidly in Epac2-/- (Rapgef4-/-) mice. (a–b) Examples of NPY-tdmOrange2
exocytosis events in b-cells from Epac2-/- mice or from wildtype littermates, stimulated with 75 mM K+ in presence
of forskolin. Note absence of a flash in Epac2 ko. (c) Fraction of flash events for experiments in (a–b); differences
are significant in absence (p=0.027, Kruskal Wallis/Dunn test) or presence of fsk (p=0.011). Number of mice: 4
(WT); 4 (Epac2 KO); 5 (WT + fsk); 2 (Epac2 KO + fsk). n, number of cells. (d) Cumulative exocytosis for experiments
in absence of forskolin (a,c left) for wildtype (black) and Epac2-/- cells (red), differences are n.s. (e) Cumulative
exocytosis for experiments in presence of forskolin (b,c right) for wildtype (black) and Epac2-/- cells (red). p=0.003,
Kruskal Wallis/Dunn test. (f–g) Cumulative frequency histograms and medians (inset) of NPY release times for
exocytotic events in d (no forskolin, 23 events for wt, 22 for Epac2-/-) and E (with forskolin, 50 events for wt, nine for
Epac2-/-). Differences in f are significant (p=0.043; Kolmogorov-Smirnov test).
DOI: https://doi.org/10.7554/eLife.41711.007
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Figure 5. Sulfonylureas cause fusion pore restriction. (a) Cartoon of the experimental design in (b–d). INS-1 cells
expressing NPY-tdmOrange2 were bathed in 10 mM glucose, diazoxide (200 mM) and either 200 mM tolbutamide
(tolb), 50 mM glibenclamide (glib) or 50 mM gliclizide (gliz); exocytosis was evoked by acute exposure to 75 mM K+.
(b) Exocytosis in absence (left) or presence (right) of fsk (2 mM) for flash events (color) and full fusions (white). Total
exocytosis was increased by sulfonylurea in absence of fsk (p=0.15 tolb; p=0.05 glib, p=0.005 gliz, Kruskal Wallis/
Dunn test vs ctrl/no fsk), but not in its presence (p=0.23 tolb; p=0.16 glib, p=0.10 glic). Sulfonylurea reduced full
fusion events in presence of fsk (p=0.0045 tolb, p=0.00032 glib, 0.022 gliz, t-test). n of preps: 4 (CTR); 3 (tolb); 2
(glib); 3 (gliz); 5 (CTR + fsk); 3 (tolb + fsk); 3 (glib + fsk); 2 (gliz + fsk). n, number of cells. (c) Fraction of flash events
for experiments in (b); Kruskal-Wallis/Dunn Test against ctrl/no fsk: p=0.015 tolb, p=0.001 glib, p=0.097 gliz, and
against control +fsk: p=0.07 tolb; p=0.002 glib; p=0.14 gliz;); n, number of cells. (d) Cumulative frequency
histograms and medians (insets) of NPY release times for (b–c). Differences vs control are significant in the
absence of fsk: p=9.1*10 4 tolb, p=0.003 glib, p=0.015 gliz, Kolmogorov-Smirnov test). Insets show NPY release
times for 38 (CTR), 74 (tolb), 79 (glib), 95 (gliz) events and inset on the right for 111 (CTR), 104 (tolb), 127 (glib) and
54 (gliz) events in presence of fsk. (e) Cartoon of the experimental design in (f–h). Cells were bathed in 10 mM
glucose, 2 mM fsk, 50 mM diazoxide and acutely exposed to sulfonylureas (500 mM tolb, 100 mM glib or 100 mM
gliz) during the recording period. (f) Exocytosis in presence of fsk (2 mM) for flash events (color) and full fusions
(white). Differences are not significant (p=0.16 Kruskal Wallis test). n, number of cells. (g) Fraction of flash events
for experiments in (f). Differences are not significant (p=0.98 Kruskal Wallis test). (h) Cumulative frequency
histograms and medians (inset) of NPY release times for (f–g). Inset shows NPY release times for 111 (CTR), 68
(tolb), 34 (glib) and 31 (gliz) events.
DOI: https://doi.org/10.7554/eLife.41711.008
Figure 5 continued on next page
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Dynamin and amisyn-controlled restriction of the fusion pore is cAMP-
dependent
The proteins dynamin and amisyn have previously been implicated in fusion pore regulation in b-cells
(Tsuboi et al., 2004; Collins et al., 2016). To understand how these proteins behave around the
release site, we expressed EGFP-tagged dynamin1 (Figure 6a) or mCherry-tagged amisyn
(Figure 6b) together with a granule marker in INS-1 cells, and stimulated exocytosis with elevated
K+. In the presence of fsk, both of the two fluorescent proteins were recruited to the granule site
during membrane fusion (Figure 6c,f, and Figure 6—figure supplement 1). Expression of both pro-
teins was about 2–4 fold compared with endogenous levels (Figure 6—figure supplement 2), and
markedly increased the NPY release times (Figure 6d, g) and flash-associated exocytosis events
(Figure 6e,h). Addition of the Epac inhibitor ESI09 prevented recruitment of both dynamin1 and
amisyn during flash events and reduced flash events and NPY release times below control
(Figure 6c–h). In the absence of fsk, expression of the two proteins had no effect on fusion pore
behavior, and only amisyn (but not dynamin1) was recruited to the exocytosis site (Figure 6i–n).
When Epac was activated with S223 (no fsk), dynamin1 and amisyn were recruited during flash
events, and NPY release times and flash events were increased for both proteins (Figure 6i–n). The
data suggest that dynamin1 and amisyn are acutely recruited to the exocytosis site, where they par-
ticipate in cAMP-dependent fusion pore restriction.
Discussion
cAMP-dependent signaling restricts fusion pore expansion and promotes kiss-and-run exocytosis in
b-cells (Hanna et al., 2009) and neuroendocrine cells (Calejo et al., 2013; Machado et al., 2001)
(but see Hatakeyama et al., 2006). We show here that the cAMP-mediator Epac2 orchestrates
these effects by engaging dynamin and perhaps other endocytosis-related proteins at the release
site (Figure 7). Since the fusion pore acts as a molecular sieve, the consequence is that insulin and
other peptides remain trapped within the granule, while smaller transmitter molecules with para- or
autocrine function are released (Obermüller et al., 2005; MacDonald et al., 2006; Taraska et al.,
2003; Leclerc et al., 2004). Incretin signaling and Epac activation therefore delays, or altogether
prevents insulin secretion from individual granules, while promoting paracrine intra-islet communica-
tion that is based mostly on release of small transmitter molecules.
Paradoxically, two clinically important classes of antidiabetic drugs, GLP-1 analogs and sulfonylur-
eas, activate Epac in b-cells and caused restriction of the fusion pore. Sulfonylureas have long been
known to stimulate insulin secretion by binding to SUR1, which results in closure of KATP channels
and depolarization (Henquin, 2000). The drugs also accelerate PKA-independent granule priming in
b-cells, which may involve activation of intracellularly localized SUR1 (Eliasson et al., 2003). Our
data indicate that sulfonylureas exert a third mode of action that leads to the restriction of the fusion
pore and therefore limits insulin release. Two pieces of evidence suggest that SUR1 is not involved
in the latter. First, acute exposure to sulfonylureas had no effect on fusion pore behavior, although it
blocks KATP channels (indicating SUR1 activation). Only long-term exposure to sulfonylurea resulted
in restricted fusion pores, likely because it allowed the drugs to enter the cytoplasm. Second, we
could not detect enrichment of SUR1 at the granule release site, which precludes any direct role of
the protein in fusion pore regulation. Sulfonylurea compounds have been shown to allosterically sta-
bilize the cAMP-dependent activation of Epac (Takahashi et al., 2013; Herbst et al., 2011). Our
finding that sulfonylurea caused fusion pore restriction in the absence of forskolin indicates that
basal cAMP concentrations are sufficient for this effect. Since gliclizide binds the CNB1 domain with-
out activating it (Takahashi et al., 2013) and still restricts the fusion pore, Epac localization at the
Figure 5 continued
The following figure supplements are available for figure 5:
Figure supplement 1. Granule pH is unchanged by forskolin or tolbutamide and does not affect pore lifetime.
DOI: https://doi.org/10.7554/eLife.41711.009
Figure supplement 2. Activation of SUR1 by tolbutamide does not affect fusion pore restriction.
DOI: https://doi.org/10.7554/eLife.41711.010
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granule site (Alenkvist et al., 2017) may be enough to regulate the downstream proteins (e.g. dyna-
min and amisyn). It can further be speculated that the competing stimulatory (via exocytosis) and
inhibitor effects (via the fusion pore) of sulfonylureas on insulin secretion, contribute to the reduction
in sulfonylurea effectiveness with time of treatment. Long-term treatment with GLP-1 analogs dis-
turbs glucose homeostasis (Abdulreda et al., 2016), and combination therapy of sulfonylurea and
Figure 6. Fusion pore regulation by dynamin1 and amisyn is cAMP-dependent. (a–b) Example image sequence of transient recruitment of dynamin1-
GFP (a, lower) or mCherry-amisyn (b, lower) to granules (upper, labeled with NPY-tdmOrange2 or NPY-EGFP) during K+-stimulated exocytosis in
presence of forskolin. (c) Average time course (± SEM) of dynamin1-GFP (dyn) fluorescence during 34 flash-type exocytosis events (red) and eight full-
fusion type events (black) in presence of forskolin; and nine flash events in presence of fsk + ESI09 (blue); data points represent average of five frames
and time is relative to the flash onset in the granule signal. (d) Cumulative frequency histograms and medians (inset, with p for Kolmogorov-Smirnov
test) of NPY release times in presence of fsk in cells expressing dynamin1-EGFP (red), dynamin with added ESI09 (blue) or control (black). 119 (CTR), 42
(dyn), 24 (dyn + ESI09) events. n of preps: 5 (C + fsk); 1 (dyn); 2 (dyn + ESI-09). (e) Fraction of flash events in (d). n, number of cells, p for Kruskal-Wallis/
Dunns test. (f) Average time course (± SEM) of mCherry-amisyn (amis) fluorescence (red n = 274 flash events; black n = 46 full fusion events) or in
presence of fsk + ESI09 (blue; n = 56 flash events). (g) Cumulative frequency histograms and medians (inset, with Kolmogorov-Smirnov test) of NPY
release times in cells expressing mCherry-amisyn, amysin with ESI09, or control; fsk was present. 213 (CTR), 320 (amisyn), and 90 (amis +ESI09) events. n
of preps: two for each. (h) Fraction of flash events in (g); p for Kruskal-Wallis/Dunn test. n, number of cells. (i) As in c, but without forskolin for control
(black), dynamin (red), and dynamin with S223 (green); n = 37 flash events, n = 39 full fusion events for dyn and n = 40 flash events for dyn +S223. (j–k)
As in (d–e), but for 38 (ctrl, black), 76 (dynamin1, red) and 55 (Dyn + S223, green) events in the absence of forskolin. n of preps: 4 (C-fsk); 2 (dyn); 2
(dyn + S223). (l) As in f, but without forskolin present; 65 flash events (red) and 73 full fusion events (black) for amisyn, and 154 flash events for
amisyn + S223 (green). (m–n) As in (g–h), but for 123 (ctrl, black), 138 (amisyn, red) and 174 (amis + S223, green) events in the absence of forskolin. n of
preps: 1 (C-fsk); 2 (amis); 2 (amis + S223).
DOI: https://doi.org/10.7554/eLife.41711.011
The following figure supplements are available for figure 6:
Figure supplement 1. NPY and amisyn/dynamin1 recruitment profiles at the point of release.
DOI: https://doi.org/10.7554/eLife.41711.012
Figure supplement 2. Quantification of overexpression.
DOI: https://doi.org/10.7554/eLife.41711.013
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DPP4 inhibitors (that elevate cAMP) has been shown to lead to severe hypoglycemia (Yabe and
Seino, 2014), an effect that likely depends on Epac (Takahashi et al., 2015).
Epac mediates the PKA-independent stimulation of exocytosis by cAMP (Seino et al., 2009) and
our data suggests it may affect both priming and fusion pore restriction. This effect is rapid
(Eliasson et al., 2003), suggesting that Epac is preassembled at the site of the secretory machinery.
Indeed, Epac concentrates at sites of docked insulin granules (Alenkvist et al., 2017), and forms
functionally relevant complexes with the tethering proteins Rim2 and Piccolo (Fujimoto et al.,
2002). However, the amount of Epac2 present at individual release sites did not correlate with fusion
pore behavior, which may indicate that the protein acts indirectly by activating or recruiting other
proteins. Indeed, we show here that recruitment of two other proteins, dynamin and amisyn,
depends on cAMP and Epac. Other known targets of Epac are the small GTPases Rap1 and R-Ras,
for which Epac is a guanine nucleotide exchange factor (GEF). Rap1 is expressed on insulin granules
and affects insulin secretion both directly (Shibasaki et al., 2007), and by promoting intracellular
Ca2+-release following phospholipase-C activation (Dzhura et al., 2011). R-Ras is an activator of
phosphoinositide 3-kinase (Marte et al., 1997). By altering local phosphoinositide levels, Epac could
therefore indirectly affect exocytosis via recruitment of C2-domain proteins such as Munc13
Figure 7. Summary of fusion pore characteristics. Fraction of events with restricted fusion pores, NPY release time and exocytosis rate for Epac2 KO
(first column), controls (second column) and with Epac2 overexpression (third column) in absence (upper rows) and presence of tolbutamide (bottom
rows). Changes in exocytosis are compared to controls without (left half columns) or with (right half columns) forskolin. See Figure 7—source data 1 for
details.
DOI: https://doi.org/10.7554/eLife.41711.014
The following source data is available for figure 7:
Source data 1.
DOI: https://doi.org/10.7554/eLife.41711.015
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(Kang et al., 2006), and fusion pore behavior by recruitment of the PH-domain containing proteins
dynamin and amisyn (Ramachandran and Schmid, 2008; Abbineni et al., 2018).
An unresolved question is whether pore behavior is controlled by mechanisms that promote pore
dilation, or that instead prevent it. Dynamin causes vesicle fission during clathrin-dependent endocy-
tosis (Marks et al., 2001), and since dynamin is present at the exocytosis site and required for the
kiss-and-run mode (Jackson et al., 2015; Tsuboi et al., 2004; Trexler et al., 2016), it may have a
similar role during transient exocytosis. An active scission mechanism is also suggested by the find-
ing that granules loose some of their membrane proteins during transient exocytosis (Tsuboi et al.,
2004; Perrais et al., 2004). Capacitance measurements have shown that fusion pores initially flicker
with conductances similar to those of large ion channels, before expanding irreversibly
(Lollike et al., 1995). This could result from pores that are initially stabilized through unknown pro-
tein interactions and that eventually give way to uncontrolled expansion. However, scission mecha-
nisms involving dynamin can act even when the pore has dilated considerably beyond limit of
reversible flicker behavior (Shin et al., 2018; Taraska and Almers, 2004; Zhao et al., 2016;
Anantharam et al., 2011), and even relatively large granules retain their size during fusion-fission
cycles (MacDonald et al., 2006; Lollike et al., 1995). Separate mechanisms may therefore operate,
one that prevents pore dilation by actively causing scission, similar to the role of dynamins in endo-
cytosis, and another by shifting the equilibrium between the open and closed states of the initial
fusion pore. Curvature-sensitive proteins are particularly attractive for such roles since they could
accumulate at the neck of the fused granule; such ring-like assemblies that have indeed been
observed for the Ca2+-sensor synaptotagmin (Wang et al., 2001). Active pore dilation has also been
proposed to be driven by crowding of SNARE proteins (Wu et al., 2017) and a-synuclein
(Logan et al., 2017).
b-cell granules contain a variety of polypeptides (insulin, IAPP, chromogranins) and small molecule
transmitter molecules (GABA, nucleotides, 5HT) that have important para- and autocrine functions
within the islet (Braun et al., 2012; Caicedo, 2013). Insulin modulates its own release by activating
b-cell insulin receptors (Leibiger et al., 2008), stimulates somatostatin release (Vergari et al.,
2019), and inhibits glucagon secretion (Ravier and Rutter, 2005). Insulin secretion is also inhibited
by IAPP/amylin and chromogranin cleavage products such as pancreastatin (Braun et al., 2012). Of
the small transmitters, GABA inhibits glucagon secretion from a-cells (Rorsman et al., 1989) and
enhances insulin secretion (Soltani et al., 2011), and tonic GABA signaling is important for the main-
tenance of b-cell mass (Soltani et al., 2011). Adenine nucleotides cause b-cell depolarization, intra-
cellular Ca2+-release and enhanced insulin secretion (Khan et al., 2014; Jacques-Silva et al., 2010),
but also negative effects have been reported (Salehi et al., 2005; Poulsen et al., 1999). Paracrine
purinergic effects also coordinate Ca2+ signaling among b-cells (Hellman et al., 2004), stimulate
secretion of somatostatin from d-cells (Bertrand et al., 1990), and target islet vasculature and mac-
rophages as part of the immune system (Weitz et al., 2018). By selectively allowing small molecule
release, Epac/cAMP-dependent fusion pore restriction is expected to alter both the timing and the
relative volume of peptidergic vs. transmitter signaling. Given that granule priming and islet electri-
cal activity are regulated on a second time scale, even small delays between these signals can be
envisioned to affect the ratio of insulin to glucagon secretion. As illustrated by the recent finding of
altered fusion pore behavior in type-2 diabetes (Collins et al., 2016), Epac-dependent fusion pore
regulation may have profound consequences for islet physiology and glucose metabolism in vivo.
Materials and methods
Key resources table
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Reagent or Resource Designation Source of Reference Identifiers Additional Information
Genetic reagent
(Mus musculus)




INS-1 Clone 832/12 (Hohmeier et al., 2000) RRID:CVCL_7226 H Mulder (Malmö)
Transfected
construct (Mus musculus)
EGFP-Epac2 (Idevall-Hagren et al., 2013) 1068
Transfected
construct (Homo sapiens)




P2X2-mRFP1 (Obermüller et al., 2005) 1226
Transfected
construct (Homo sapiens)










dynamin1-GFP W Almers (Portland) 1342
Transfected
construct (Homo sapiens)
NPY EGFP W Almers (Portland) 1008
Biological sample
(Homo sapiens)









ab52852 abcam PMID:28171750 1/50
Chemical
compound, drug
Cell dissociation buffer Thermo Fisher 13150016
Chemical
compound, drug
Trypsin solution Thermo Fisher 12604–021
Chemical
compound, drug
Lipofectamine 2000 Thermo Fisher 11668–019
Chemical
compound, drug



























Gliclizide; gliz Sigma-Aldrich 21187-98-4
Continued on next page
Guček et al. eLife 2019;8:e41711. DOI: https://doi.org/10.7554/eLife.41711 14 of 22
Research article Cell Biology Human Biology and Medicine
Continued
Reagent or Resource Designation Source of Reference Identifiers Additional Information
Chemical
compound, drug





Human islets were obtained from the Nordic Network for Clinical Islet Transplantation Uppsala
(Goto et al., 2004) under full ethical clearance (Uppsala Regional Ethics Board 2006/348) and with
written informed consent. Isolated islets were cultured free-floating in sterile dishes in CMRL 1066
culture medium containing 5.5 mM glucose, 10% fetal calf serum, 2 mM L-glutamine, streptomycin
(100 U/ml), and penicillin (100 U/ml) at 37˚C in an atmosphere of 5% CO2 up to 2 weeks. Prior to
imaging, islets were dispersed into single cells by gentle agitation using Ca2+-free cell dissociation
buffer (Thermo Fisher Scientific) supplemented with 10% (v/v) trypsin (0.05% Thermo Fisher Scien-
tific). INS1-cells clone 832/13 (Hohmeier et al., 2000) were maintained in RPMI 1640 (Invitrogen)
with 10 mM glucose, 10% fetal bovine serum, streptomycin (100 U/ml), penicillin (100 U/ml), Sodium
pyruvate (1 mM), and 2-mercaptoethanol (50 mM). The ins1 832/13 cells were screened by PCR and
found negative for mycoplasma.
Mouse islets were isolated from 5 to 12 months old WT and Epac2-/- (Kopperud et al., 2017)
(Rapgef4-/-) animals. The Epac2 deletion involves exons 12–13, which include the high-affinity cAMP
binding domain present in all Epac2 isoforms, in contrast to previously reported knockout strain
(Shibasaki et al., 2007), which only lacks the Epac2A isoform. The mice were anesthetized and the
pancreas dissected out and cleared from fat and connective tissue in ice-cold Ca5 solution (in mM
125 NaCl, 5KCl, 1.2 MgCl2, 1.28 CaCl2, 10 HEPES; pH 7.4 with NaOH). Pancreas was injected with
Collagenase P (1 mg/ml) and cut into small pieces before mechanical dissociation (7 min at 37˚C).
BSA was added immediately and islets were washed 3X with ice cold Ca5 buffer with BSA. Islets
were dispersed into single cells using Ca2+-free cell dissociation buffer (supplemented with 10% (v/v)
trypsin) and gentle agitation. Dispersed cells were sedimented by centrifugation, resuspended in
RPMI 1640 medium (containing 5.5 mM glucose, 10% fetal calf serum, 100 U/ml penicillin and 100
U/ml streptomycin).
The cells were plated onto 22 mm polylysine-coated coverslips and were transduced the next day
using adenovirus (human and mouse cells) or transfected the same day with plasmids (INS1 cells,
using Lipofectamine2000, Invitrogen) encoding the granule markers NPY-Venus, NPY-EGFP or NPY-
tdOrange. Imaging proceeded 24–36 hr later.
Constructs
The open-reading frame of human amisyn (NM_001351940.1) was obtained as a synthetic DNA frag-
ment (Eurofins, Germany) and was cloned into pCherry2 C1 (Addgene, plasmid nr 54563) by seam-
less PCR cloning. The linker between Cherry2 and amisyn translates into the peptide
SGLRSRAQASNSAV. The plasmid N1 NPY-EGFP-mCherry coding for NPY-linker(TVPRARDPPVAT)-
EGFP-linker(KRSGGSGGSGGS)-mCherry was made by seamless PCR cloning. The correct open-
reading frame of both Cherry2-linker-amisyn and NPY-EGFP-mCherry was confirmed by Sanger
sequencing (Eurofins, Germany). The NPY-tdOrange2 adeno virus was made using the RAPAd vector
system (Cell Biolabs, San Diego). NPY-tdOrange2 (Gandasi et al., 2015) was cloned into the pacAd5
CMVK-NpA Shuttle plasmid (Cell Biolabs). Virus was produced in HEK293 cells and isolated accord-
ing to the instructions of the manufacturer (Cell Biolabs).
Solutions
Cells were imaged in (mM) 138 NaCl, 5.6 KCl, 1.2 MgCl2, 2.6 CaCl2, 10 D-glucose 5 HEPES (pH 7.4
with NaOH) at 32–34˚C. Exocytosis was evoked with high 75 mM K+ (equimolarly replacing Na+),
applied by computer-timed local pressure ejection through a pulled glass capillary. For K+-induced
exocytosis, spontaneous depolarizations were prevented with 200 mM diazoxide (50 mM for
Figure 5e–h). In Figure 5e–h, exocytosis was evoked by sulfonylureas (500 mM tolbutamide, 200 mM
glibenclamide or 200 mM gliclizide). For electrophysiology, glucose was reduced to 3 mM, and the
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electrodes were filled with (mM) 125 CsCl, 10 NaCl, 1.2 MgCl2, 5 EGTA, 4 CaCl2, 3 Mg-ATP, 0.1
cAMP, 10 HEPES (pH 7.15 using CsOH).
Immunocytochemistry
To quantify the overexpression, INS-1 cell were transfected with either Cherry2-amisyn or Dynamin1-
GFP, fixed 24 hr later in 3.8% formaldehyde in phosphate-buffered saline (PBS) for 30 min at 25˚C
and washed in PBS. The cells were permeabilized in 0.2% Triton X-100 in PBS for 5 min and washed
in PBS. Blocking was done using 5% FBS in PBS for 1–2 hr at 25˚C. Cells were then incubated with a
primary antibody (anti-Dynamin1, ab52852 abcam or anti-Amisyn, ab153974 abcam) both diluted 1/
50 in 5% FCS in PBS over night at 4˚C and washed again in PBS. Incubation with secondary antibody
(Alexa Fluor 488 anti-rabbit or Alexa Fluor 555 anti-rabbit, Invitrogen) diluted 1/1000 in 5% FCS in
PBS was performed for 1 hr at 25˚C and subsequently the cells were washed in PBS.
TIRF microscopy
Human cells were imaged using a lens-type total internal reflection (TIRF) microscope, based on an
AxioObserver Z1 with a 100x/1.45 objective (Carl Zeiss). TIRF illumination with a calculated decay
constant of ~100 nm was created using two DPSS lasers at 491 and 561 nm (Cobolt, Stockholm,
Sweden) that passed through a cleanup filter (zet405/488/561/640x, Chroma) and was controlled
with an acousto-optical tunable filter (AA-Opto, France). Excitation and emission light were sepa-
rated using a beamsplitter (ZT405/488/561/640rpc, Chroma) and the emission light chromatically
separated (QuadView, Roper) onto separate areas of an EMCCD camera (QuantEM 512SC, Roper)
with a cutoff at 565 nm (565dcxr, Chroma) and emission filters (ET525/50 m and 600/50 m, Chroma).
Scaling was 160 nm per pixel.
INS1 and mouse cells were imaged using a custom-built lens-type TIRF microscope based on an
AxioObserver D1 microscope and a 100x/1.45 NA objective (Carl Zeiss). Excitation was from two
DPSS lasers at 473 nm and 561 nm (Cobolt), controlled with an acousto-optical tunable filter (AOTF,
AA-Opto) and using dichroic Di01-R488/561 (Semrock). The emission light was separated onto the
two halves of a 16-bit EMCCD camera (Roper Cascade 512B, gain setting at 3800 a.u. throughout)
using an image splitter (DualView, Photometrics) with ET525/50 m and 600/50 m emission filters
(Chroma). Scaling was 100 nm per pixel for INS-1 experiments and 160 nm for mouse cells. The
frame rate was 10 frames*s 1, with 100 ms exposures.
Image analysis
Exocytosis events were identified manually based on the characteristic rapid loss of the granule
marker fluorescence (most fluorescence lost within 1–2 frames) in cells which exhibited minimum of 1
event/cell (except mouse cells, where all cells were included). Events were classified as flash events if
they exhibited an increase in the fluorescence signal before the rapid loss of the granule fluores-
cence. The NPY release times were obtained for both types of events by non-linear fitting with a dis-
continuous function in Origin as described previously (Gandasi et al., 2015). Protein binding to the
release site (DF/S) was measured as described previously (Gandasi and Barg, 2014).
Electrophysiology
ATP release was measured in INS1 cells expressing RFP-tagged P2X2 receptor (Obermüller et al.,
2005). Cells were voltage-clamped in whole-cell mode using an EPC-9 amplifier and PatchMaster
software (Heka Elektronik, Lambrecht, Germany) with patch-clamp electrodes pulled from borosili-
cate glass capillaries that were coated with Sylgard close to the tips, and fire-polished (resistance 2–
4 MW). The free [Ca2+] was calculated to be 600 nM (WEBMAXC standard) and elicited exocytosis
that was detected as P2X2-dependent inward current spikes. Currents were filtered at 1 kHz and
sampled at 5 kHz. Spike analysis was performed using automated program for amperometric record-
ings in IGOR Pro (Segura et al., 2000), with the threshold set at eight times the RMS noise during
event-free section of recording.
Statistics
Data are presented as mean ± SEM unless otherwise stated. Statistical significance was tested
(unless otherwise stated) and is indicated by asterisks (*p<0.05, **p<0.01, ***p<0.001). The not
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normally distributed exocytosis rates and ratios of flash events were tested with Kruskal Wallis with
post hoc Dunn test and NPY release times were tested with Kolmogorov-Smirnov test.
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P, Thévenod F. 1999. The stimulatory action of tolbutamide on Ca2+-dependent exocytosis in pancreatic beta
cells is mediated by a 65-kDa mdr-like P-glycoprotein. PNAS 96:5539–5544. DOI: https://doi.org/10.1073/pnas.
96.10.5539, PMID: 10318919
Barg S, Olofsson CS, Schriever-Abeln J, Wendt A, Gebre-Medhin S, Renström E, Rorsman P. 2002. Delay
between fusion pore opening and peptide release from large dense-core vesicles in neuroendocrine cells.
Neuron 33:287–299. DOI: https://doi.org/10.1016/S0896-6273(02)00563-9, PMID: 11804575
Ben-Othman N, Vieira A, Courtney M, Record F, Gjernes E, Avolio F, Hadzic B, Druelle N, Napolitano T, Navarro-
Sanz S, Silvano S, Al-Hasani K, Pfeifer A, Lacas-Gervais S, Leuckx G, Marroquı́ L, Thévenet J, Madsen OD, Eizirik
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